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Abstract
RNA polymerase II transcribes the physical ends of linear eukaryotic chromosomes into a variety of long non-coding RNA
molecules including telomeric repeat-containing RNA (TERRA). Since TERRA discovery, advances have been made in the
characterization of TERRA biogenesis and regulation; on the contrary its associated functions remain elusive. Most of the
biological roles so far proposed for TERRA are indeed based on in vitro experiments carried out using short TERRA-like RNA
oligonucleotides. In particular, it has been suggested that TERRA inhibits telomerase activity. We have exploited two
alternative cellular systems to test whether TERRA and/or telomere transcription influence telomerase-mediated telomere
elongation in human cancer cells. In cells lacking the two DNA methyltransferases DNMT1 and DNMT3b, TERRA
transcription and steady-state levels are greatly increased while telomerase is able to elongate telomeres normally. Similarly,
telomerase can efficiently elongate transgenic inducible telomeres whose transcription has been experimentally
augmented. Our data challenge the current hypothesis that TERRA functions as a general inhibitor of telomerase and
suggest that telomere length homeostasis is maintained independently of TERRA and telomere transcription.
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Introduction
The physical ends of linear eukaryotic chromosomes are
transcribed into a variety of non-coding RNA (ncRNA) species
constituting the ‘telomeric transcriptome’. Among these species,
the long ncRNA TERRA (telomeric repeat-containing RNA) was
first discovered in mammalian cells and successively described in
non-mammalian eukaryotes including zebrafish, Arabidopsis thali-
ana, the budding yeast Saccharomyces cerevisiae and the fission yeast
Schizosaccharomyces pombe [1–7]. TERRA molecules are transcribed
from the regions immediately preceding the telomeres -the
subtelomeres- towards the end of the chromosomes primarily by
the DNA-dependent RNA polymerase II (RNAPII), which uses
the telomeric C-rich strand as a template. Hence, individual
TERRA molecules comprise a subtelomeric tract and G-rich
telomeric repeats (59-UUAGGG-39 in mammals). TERRA
remains associated to telomeres post-transcriptionally suggesting
that TERRA is a constitutive component of telomeric hetero-
chromatin [1,3,4,6]. Other RNA species transcribed from
chromosome ends comprise ARIA, a C-rich telomeric RNA so
far identified only in fission yeast and plants, and two
complementary subtelomeric transcripts devoid of detectable
telomeric repeats named ARRET, identified in budding and
fission yeasts, and aARRET, identified only in fission yeast
[1,4,5,7].
Subtelomeric promoters driving the transcription of TERRA
have been identified in human cells and comprise CpG
dinucleotide-rich islands composed of stretches of 29 and 37 bp
tandem repeats (29–37 repeats). 29–37 repeats are preceded by
tandemly repeated 61 bp units that are dispensable for promoter
activity and of so far uncharacterized function [8,9]. CpG
dinucleotides within TERRA promoters are heavily methylated
in different cancer and primary cells [9]. In human colorectal
carcinoma HCT116 cells knocked out for the two DNA
methyltransferase enzymes DNMT1 and DNMT3b (DKO cells),
TERRA promoter methylation is completely abolished and
RNAPII binding to TERRA promoters and TERRA steady-state
levels are markedly augmented [9]. Thus, the concerted activity of
DNMT1 and 3b restricts TERRA promoter transcriptional
activity, at least in HCT116 cells. Similarly, decreased subtelo-
meric CpG methylation is accompanied by increased TERRA
cellular levels in cells derived from human patients affected by
immunodeficiency, centromeric region instability, facial anomalies
(ICF), a recessive syndrome deriving from germline mutations in
the DNMT3b gene [10]. Strangely, TERRA abundance is
reduced in mouse cells deficient for DNMT1 and DNMT3a/b,
although global methylation of subtelomeres is compromised,
suggesting species-specific mechanisms of TERRA regulation
mediated by DNMTs [6,11]. Indeed, TERRA promoters are still
to be characterized in mouse cells and it remains possible that
murine TERRA promoters are not regulated through CpG
methylation.
While TERRA biogenesis and regulation have been extensively
studied, a lack of reproducible experimental tools to alter TERRA
cellular levels accounts for the sparse knowledge of TERRA-
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TERRA were deduced from in vitro experiments where short
TERRA-like RNA oligonucleotides were employed. Such in vitro
experiments have suggested that TERRA might regulate telomere
length homeostasis, telomere replication and telomeric DNA
condensation [6,12–14]. In particular, TERRA-like oligonucleo-
tides strongly inhibited telomerase activity in telomeric repeat
amplification protocol (TRAP) and telomerase direct assays [6,14].
Therefore, it is generally assumed that TERRA acts as a general
inhibitor of telomerase-mediated telomere elongation and a few
indirect in vivo evidences apparently support this assumption. A
budding yeast telomere artificially forced to transcribe underwent
shortening, while the length of the remaining telomeres was
unaffected [15]. Yeast mutants with compromised Rat1p RNA
exonuclease activity bear higher amounts of TERRA molecules
and shorter telomeres as compared to wild type counterparts [16].
Finally, telomeres are shorter in cells established from ICF patients
than in cells from healthy donors [10]. Nevertheless, it has not
been directly tested whether the telomere shortening observed in
these different cellular systems truly derives from telomerase
inhibition. Thus, the actual biological relevance of the ability of
TERRA-like oligonucleotides to inhibit telomerase activity in vitro
still remains to be assessed.
In order to determine whether TERRA and telomere
transcription affect telomerase activity in vivo, we have exploited
two alternative human cellular systems where TERRA transcrip-
tion is augmented. We show that DKO cells infected with
retroviruses expressing the catalytic subunit of telomerase elongate
their telomeres as efficiently as parental cells with intact DNMT
activities. Consistently, telomerase biochemical activity appears
not to be affected in the same cells. We also present the
development of a cellular system where transcription of unique
‘transcriptionally inducible telomeres’ (tiTELs) can be controlled
at will. Transcription induction of tiTELs does not affect their
homeostatic length, nor does it prevent telomerase-mediated re-
elongation upon shortening induced by telomerase inhibitors.
Altogether our results challenge the commonly accepted notion
that TERRA is a cellular inhibitor of telomerase and beg for
exploring alternative functions exerted by TERRA and telomere
transcription. In addition, our results imply that the telomere
shortening observed in systems where TERRA was aberrantly
elevated [10,15,16] likely derives from compromised telomere
integrity rather than telomerase inhibition.
Results and Discussion
TERRA steady-state levels are maintained independently
of telomere length in human cancer cells
The proposed role for TERRA in inhibiting telomerase activity
has suggested a model where long telomeres accumulate or
produce more TERRA, thereby preventing telomerase to further
extend them [6,14,17]. Correlative evidence using non-isogenic
mammalian cells lines of different origins seems to support this
hypothesis [6]. On the contrary, recent work in budding yeast has
shown that experimentally induced over-elongation or shortening
of telomeres does not alter TERRA levels and RNAPII occupancy
at chromosome ends [18]. We therefore set up to test whether a
correlation exists between TERRA levels and telomere length in
isogenic human cells with telomeres of different lengths.
We stably infected cervical cancer HeLa cells with retroviruses
expressing the catalytic subunit of human telomerase (hTERT). As
a control, we infected the same cells with empty vector (ev)
retroviruses or with retroviruses expressing hTERT C-terminally-
fused to an influenza hemagglutinin epitope tag (hTERT-HA).
hTERT-HA displays normal catalytic activity in vitro but fails to
elongate telomeres in vivo, likely due to impaired recruitment to
telomeres [19]. Stably infected populations were selected and
maintained in culture for several population doublings (PDs).
Telomere restriction fragment (TRF) analysis of genomic DNA
indicated that at the time when the experiments were performed
hTERT infection had led to a substantial elongation of bulk
telomeres: TRFs were comprised between 2 and 5 kb in ev-
infected cells and between 5 and more than 15 kb in hTERT-
infected cells (Figure 1A). As anticipated, hTERT-HA expression
did not alter telomere length, although it was expressed at levels
comparable to hTERT (Figure 1A and E). We then digested
genomic DNA with MspI or with its CpG methylation sensitive
isoschizomer HpaII and hybridized it to radiolabelled probes
corresponding to the 29–37 repeats found within TERRA
promoters. Consistent with what we have previously reported
[9], we found that 29–37 repeats are largely methylated in HeLa
cells. The restriction pattern detected with 29–37 repeat probes
was not altered in hTERT-expressing cells as compared to ev and
hTERT-HA control cells, indicating that telomere elongation does
not affect the methylation state of TERRA promoters (Figure 1B).
Northern blot analysis of total RNA using telomeric probes did not
disclose any substantial changes in total TERRA cellular levels in
hTERT-infected cells as compared to ev- or hTERT-HA-infected
controls (Figure 1C). A size shift of TERRA molecules towards
higher molecular weights was evident in cells with elongated
telomeres, suggesting that at least in these cell lines telomere length
might influence the length of TERRA molecules (Figure 1C).
Consistent with the northern blot analysis, quantitative real-time
PCR (qRT-PCR) measurements of TERRA molecules transcribed
from chromosome arms 10q, 15q and XpYp revealed no statistical
significant change in TERRA steady-state levels upon telomere
elongation (Figure 1D). We also performed analogous experiments
in primary human lung fibroblasts (HLF) and, as for HeLa cells,
telomere elongation did not significantly alter the methylation state
of TERRA promoters and cellular TERRA levels (Figure S1).
In a complementary approach, we cultured HeLa cells in
presence of the telomerase inhibitor BIBR1532 [20] for approx-
imately 19 weeks. BIBR1532 treatment led to a substantial
shortening of bulk telomeres: telomere length was mostly
comprised between 2 and 5 kb in untreated control cells and
between 1 and 3 kb in BIBR1532-treated cells (Figure 2A).
Treated cells divided similarly to untreated cells indicating that
telomeres were long enough to sustain normal cell growth (data
not shown). Telomere shortening did not induce any substantial
change in the methylation state of 29–37 repeats nor in total or
chromosome specific TERRA steady-state levels (Figure 2B–D).
Altogether, these experiments indicate that, as recently shown for
budding yeast [18], telomere length alterations do not affect
TERRA promoter methylation or TERRA cellular levels in
human cells. We conclude that TERRA transcription is not
regulated by telomere length, at least in the cell types that we have
analyzed.
DNA methyltransferase-deficient cells have normal
telomerase activity
The elevated TERRA levels present in DKO cells make them a
suitable cellular system to test the effects exerted by TERRA on
telomerase activity. We stably infected DKO and HCT116
parental (par) cells with hTERT or ev retroviruses and selected
stable populations. Possibly due to the different transcriptional
state of the two cell lines, we repeatedly found that over-expressed
hTERT protein levels were more than two-fold higher in par than
in DKO cells (Figure 3A). As shown by qRT-PCR and northern
Telomerase and Telomere Transcription
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61-29-37 repeat-containing 10q and 15q chromosome ends were
dramatically increased in DKO cells (Figures 3B and S2A) and,
consistently with the results above described for HeLa and HLF
cells, hTERT stable expression did not alter TERRA amounts in
either cell line (Figure 3B). We prepared protein extracts and
analyzed telomerase activity using quantitative TRAP assays. No
significant difference in telomerase activity was measured in ev-
infected par and DKO cells, while hTERT infection led to a
substantial increase in telomerase activity in both cell lines
(Figure 3C and D). TRAP activity was slightly higher in
hTERT-infected par cells than in hTERT-infected DKO cells
and we ascribe this difference to the lower amounts of total
hTERT protein expressed in the DNMT-deficient cell line
(Figure 3A, C and D). RNA isolated from TRAP extracts
contained 10q and 15q TERRA molecules, although a large
fraction of them (approximately 90 and 80% for par and DKO
cells, respectively) remained in the cell pellets left after extraction
(Figure 3E), likely because the majority of TERRA is chromatin
associated [1,3,6]. Still, considering that 10q and 15q TERRA
molecules are ,300-fold more abundant in DKO than in par cells
(Figure 3B), we estimate that DKO TRAP extracts contained
,600-fold more TERRA molecules than par extracts. In
conclusion, we report that TRAP activity is similar in cells with
drastically different TERRA levels. This is in stark contrast with
results obtained in vitro using short TERRA-like oligonucleotides
[6,14]. We believe that the short RNA oligonucleotides employed
in vitro do not behave as natural, long TERRA molecules, possibly
due to their use in high, non-physiological concentrations.
Efficient telomerase-mediated telomere elongation in
DKO cells
To monitor how telomerase elongates telomeres in par and
DKO cells we prepared genomic DNA from infected cells 2, 5 and
9 days after infection. We then performed TRF analysis using
probes specifically detecting chromosome 10q subtelomeric
sequences or telomeric repeat probes detecting bulk telomeres.
Although 10q and bulk TRFs were substantially shorter in DKO
than in parental cells, they both underwent progressive lengthen-
ing throughout the chosen time-course in cells infected with
hTERT but not in ev control cells (Figure 4A). Thus, telomerase is
able to elongate telomeres both in par and DKO cells including
10q telomeres, which are heavily transcribed in DKO cells
(Figures 3B and S2A). To gain more quantitative data, we made
use of single telomere length analysis (STELA), a PCR-based
approach that allows to precisely measure the length of individual
telomeres [21]. STELA of 15q telomeres confirmed that the
average telomere length in DKO cells is lower than in parental
cells (5.9 kb and 3.8 kb in par and DKO cells, respectively;
Figure 4B and C). Nevertheless, as already suggested by TRF
analysis, 15q telomeres were efficiently elongated in both cell lines
infected with hTERT retroviruses (Figure 4D). By quantitative
analysis of STELA products and normalization through the
population doubling (PD) time calculated for the two cell lines
Figure 1. TERRA steady-state levels are not affected by telomere elongation in HeLa cells. (A) TRF analysis of HeLa cells infected with
empty vector (ev), hTERT or hTERT-HA retroviruses. DNA was digested with RsaI and HinfI restriction enzymes and hybridized with telomeric probes.
(B) The same DNA as in A was digested with HpaII (methylation sensitive) or MspI (methylation insensitive) restriction nucleases and hybridized with a
probe detecting the 29–37 bp repeats of TERRA promoters. (C) Nuclear RNA was hybridized using telomeric probes to detect total TERRA and
successively with 18S rRNA probes to control for loading. Numbers at the bottom are the ratios between TERRA and 18S signal expressed as fold
increase over ev-infected samples. Molecular weights are on the left in kilobases. (D) qRT-PCR analysis of the steady-state levels of TERRA transcripts
originating from 10q, 15q and Xp/Yp chromosome ends. Bars are averages from three independent experiments expressed as fold increase over ev-
infected samples. Error bars and numbers are standard deviations and P-values, respectively. (E) Western blot analysis of infected cells using anti-
hTERT (to detect all hTERT molecules), anti-HA (to detect hTERT-HA) and anti-PCNA (loading control) antibodies.
doi:10.1371/journal.pone.0035714.g001
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respectively) we estimated that telomerase elongation rates were
approximately ,204 bp/PD in par cells and ,186 bp/PD in
DKO cells (Figure 4C and D). This slight difference in telomerase
elongation rates does not correlate with the enormously increased
levels of 15q TERRA in DKO cells (Figure 3B) and is likely to be
ascribed to the different hTERT protein levels detected in infected
par and DKO cells (Figure 3A). Trypan blue staining and
fluorescence-activated cell sorter (FACS) analysis of Annexin V
and propidium iodide-stained cells did not reveal any major
difference in the fraction of dead or apoptotic cells in the different
cell lines nor did it show substantial changes in the distribution of
cells among the different phases of the cell cycle (Figure S2B). This
indicates that the higher PD time measured for DKO cells is likely
attributable to a longer cycling time of these cells, a notion further
corroborated by the evident delay in cell cycle progression
observed for synchronized DKO cells released from a nocodazole
block (Figure S3A).
Normal telomere elongation in hTERT infected DKO cells
does not support the notion that TERRA functions as a telomerase
inhibitor in vivo. Still, we considered the possibility that TERRA
transcripts in DKO cells are unable to inhibit telomerase either
because they do not properly localize to telomeres or because they
are drastically down-regulated during S-phase, when telomerase is
acting [17,22]. We combined indirect immunofluorescence with
RNA fluorescence in situ hybridization (IF/RNA-FISH) to
simultaneously detect the telomeric factor TRF2 and TERRA
molecules. DKO cells contained more and brighter TERRA foci
than parental cells and hTERT infections did not alter the overall
pattern of TERRA hybridization. Approximately 20 and 30% of
TRF2 foci co-localized with TERRA foci in par and DKO cells,
respectively (Figure S2C and D), most likely reflecting the fact that
the increased levels of TERRA in DKO cells facilitated the
detection of TERRA foci. On the other hand, the fraction of
TERRA foci co-localizing with telomeres was similar in both
cellular backgrounds, indicating that the intrinsic ability of
TERRA to remain associated to telomeric heterochromatin does
not require intact DNMT activities (Figure S2C and D).
Importantly, hTERT expression did not alter the co-localization
rates in either cell line. Hence, the fraction of TERRA associated
to telomeres is similar in par and DKO cells, and telomere
elongation does not noticeably affect TERRA localization. We
then blocked par and DKO cells in G2/M phase and released
them synchronously into the cell cycle for a time sufficient to
progress through S-phase (Figure S3A). We prepared total RNA at
different time points and dot-blot hybridized it to TERRA and
actin probes. TERRA levels remained stable throughout the entire
time course in both cell lines (Figure S3B and C). Altogether, these
observations disclose that telomerase-mediated telomere elonga-
tion is not substantially impaired in DKO cells, where TERRA
transcription rates and steady-state levels are dramatically
increased [9]. This lack of robust inhibition does not stem from
mislocalization of TERRA or from its down-regulation during S-
phase. This is well in line with our observations that telomerase
activity is unaffected in the same cell lines.
Generation of human cancer cell lines carrying
transcriptionally inducible telomeres
DNMT1/3b deletion leads to global transcriptional changes in
DKO cells [23]. To obtain a cellular system in which transcription
of unique telomeres could be altered, we generated stable cell lines
carrying transgenic telomeres that can be transcribed in an
inducible fashion (‘transcriptionally inducible telomeres’; tiTELs).
We combined the telomere seeding phenomenon with the
inducible gene expression Tet-ON technology [24–26] and
engineered a telomere seeding vector comprising a hygromycin
resistance cassette and a doxycycline (DOX)-inducible minimal
CMV promoter placed upstream of a (TTAGGG)n telomeric
array (Figure 5A). A ,1.6 kb unique sequence referred to as
‘transcriptionally inducible subtelomere’ (tiSUBTEL) separates the
telomeric sequence from the inducible promoter (Figure 5A). The
seeding plasmid was linearized by ApaI digestion in order to expose
the telomeric tract at its 39 end and transfected into a Tet
repressor-expressing cell line derived from HeLa cells (T-Rex-
HeLa). Independent hygromycin-resistant clones were selected
and tested for tiTEL seeding by Southern blot analysis. Genomic
DNA was digested with XhoI in order to release tiTEL TRFs and
hybridized using radiolabeled probes corresponding to tiSUBTEL
Figure 2. TERRA steady-state levels are not affected by
telomere shortening in HeLa cells. (A–D) HeLa cells were treated
with the telomerase inhibitor BIBR1532 (+BIBR) for 19 weeks or left
untreated (2BIBR). Telomere length, TERRA promoter methylation and
total or chromosome specific TERRA steady-state levels were analyzed
as in Figure 1. Total RNA was used for all experiments. For northern blot
analysis of total TERRA (C) beta-actin (ACT) was used as a normalization
control. Molecular weights are on the left in kilobases.
doi:10.1371/journal.pone.0035714.g002
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the typical smearing hybridization pattern expected for newly
seeded tiTELs (Figure 5B) and were chosen for further
characterization. In both clones, tiTEL TRFs were mostly
comprised between 3 and 6 kb. Because XhoI cuts approximately
2.4 kb upstream of the first telomeric repeat on the seeding
plasmid (Figure 5A), tiTELs telomeric tracts were stabilized at
approximately 0.6 to 3.4 kb, a size range comparable to the one of
bulk telomeres in parental and in clonal cells (Figure S4A). We
further confirmed tiTEL seeding in clones 12 and 17 using
additional experimental approaches. We stably infected both
clonal cell lines with hTERT-expressing retroviruses and con-
firmed that both tiTELs and natural telomeres were readily
elongated upon hTERT infection (Figures 5B and S4A). STELA
with oligonucleotides corresponding to tiSUBTEL sequences
produced amplification products hybridizing to both SBP and
telomeric probes only when we used genomic DNA from cl12 and
cl17 cells but not from parental cells (Figure S4B). DNA FISH of
metaphase chromosomes prepared from cl12 and cl17 cells using
fluorescently labeled seeding plasmids devoid of telomeric repeats
revealed that newly seeded tiTELs were integrated at one and two
chromosome ends in clone 17 and in clone 12 cells, respectively
(Figure 5C). Finally, dot blot hybridization of genomic DNA
digested with the BAL31 exonuclease revealed a progressive
disappearance of tiTEL hybridization signals over time (Figure
S4C).
Transcription induction of tiTELs
To test whether tiTELs responded to transcription induction,
we cultured cl12 and cl17 cells in presence or absence of
doxycycline (DOX) for 24 hours. We collected total RNA and
subjected it to northern blot analysis using SBP probes (Figure 5A).
DOX treatment led to the appearance of RNA species, referred to
as ‘transcriptionally inducible TERRA’ (tiTERRA), comprised in
length between approximately 0.5 and 6 kb (Figure 5D). Because
the inducible promoter sequence is placed approximately 1.6 kb
Figure 3. Cells deficient for DNMT1 and 3b display normal telomerase activity. (A) Western blot analysis of hTERT-expression in HCT116
parental (par) or DNMT1 and 3b double KO (DKO) infected cells. Numbers at the bottom are the ratios between hTERT and PCNA (loading control)
signals, expressed as fold increase over hTERT-infected parental cells. (B) qRT-PCR analysis of the steady-state levels of TERRA transcripts originating
from 10q and 15q chromosome ends expressed as fold increase over ev-infected par cells. Bars and error bars are averages and standard deviations
from three independent experiments. (C) Analysis of TRAP amplification products from the indicated cells lines. Three different amounts of total
proteins were used for each cell line and to control for specificity one sample was pre-treated with RNase A. Control primers amplifying an internal
control (IC) were included in all reactions. (D) Quantification of telomerase activity in the indicated samples using qRT-PCR-based TRAP assays. Bars
and error bars are averages and standard deviations from three independent experiments, after normalization through ev-infected parental cell
samples. Numbers indicate P-values (*: P,0.01). (E) qRT-PCR-based quantification of 10q and 15q TERRA transcripts in TRAP extracts (ext) or in cell
pellets left after extraction (plt). Relative TERRA amounts are expressed as fractions of total TERRA molecules from pellet plus extract. Bars and error
bars are averages and standard deviations from three independent experiments.
doi:10.1371/journal.pone.0035714.g003
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transcription can proceed through most of the telomeric tract. We
then performed qRT-PCR analysis by reverse transcribing RNA
with random hexamers and PCR amplifying the obtained cDNA
using SBF and SBR oligonucleotides (Figure 5A). As expected, no
tiTERRA was detected in parental cells, confirming the specificity
of the RT-PCR approach (Figure 5E). Although at low levels,
tiTERRA transcripts were already detected in both uninduced
clones, revealing a basal transcriptional activity from the inducible
CMV promoter in absence of induction (Figure 5E). Absolute
quantifications of tiTERRA molecules indicated that, in unin-
duced clones, tiTERRA was maintained at levels comparable to
the ones of endogenous TERRA molecules transcribed from 10q
chromosome ends (Figure S5A and B). This indicates that
tiTERRA is maintained at physiological levels in both clonal cell
lines. Consistent with the northern blot results, DOX treatment
induced a 10-to-20-fold increase in tiTERRA levels in both clones
(Figures 5E and S5B). TiTERRA molecules were also detected in
PCR experiments performed with cDNA reverse transcribed using
C-rich oligonucleotides (TelC) complementary to the telomeric
stretch within TERRA molecules (Figure S5A and C). Thus, as
with natural TERRA, individual tiTERRA transcripts contain
both telomeric and subtelomeric sequences.
TERRA expression is epigenetically regulated and the histone
deacetylase inhibitor trichostatin A (TSA) promotes accumulation
of TERRA transcripts in human cancer cells [27]. We treated cl12
and cl17 cells with TSA in presence or absence of DOX and
quantified tiTERRA by qRT-PCR. TSA alone already induced
mild accumulation of tiTERRA molecules in both cell lines, while
concomitant treatments with TSA and DOX led to a 25-to-38-fold
increase in tiTERRA molecules as compared to untreated control
cells (Figure 5E). Therefore, as with natural telomeres, tiTELs are
embedded within heterochromatin and their transcription is
repressed through mechanisms that require histone deacetylation.
We also measured tiTERRA levels in cl12 and cl17 cells bearing
elongated telomeres due to stable infection with hTERT
retroviruses and found no statistically significant difference as
compared to ev-infected control cells (Figure 5E). This indicates
that telomere elongation does not influence tiTERRA expression
and suggests that tiTEL transcription, similarly to the one of
endogenous telomeres, is not controlled by canonical telomere
position effect [28].
Figure 4. Efficient telomerase-mediated elongation of telomeres in DKO cells. (A) TRF analysis of par and DKO cells infected with empty
vector (ev) or hTERT retroviruses. Genomic DNA was collected 2, 5 and 9 days (d) after infection, digested with RsaI and transferred to a nylon
membrane. The same membrane was first hybridized with a probe detecting 10q TRFs and successively with a probe detecting total telomeres. (B)
STELA of 15q telomere length using the same DNA as in A. Marker molecular weights are on the left in kilobases. (C) Box plot representation of 15q
telomere lengths. Average telomere lengths in kilobases and the number of total telomeres analyzed (n) are indicated for each sample. (D) 15q
telomere elongation rates expressed as average telomere length at different population doublings. Note that for par cells, only three time points
were used because no statistically significant difference in average telomere length was measured between day 5 and day 9.
doi:10.1371/journal.pone.0035714.g004
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induction
To monitor whether tiTEL length homeostasis was affected by
transcription induction, we cultured cl12 and cl17 cells in presence
or absence of DOX for approximately 60 PDs. As a control we
also treated cells with BIBR1532. Quantitative RT-PCR analysis
performed at various time points during the course of the
experiment confirmed that that tiTERRA induction was main-
tained in DOX-treated cells (data not shown). Moreover, the
growth rates of DOX-treated and untreated cells were undistin-
guishable (data not shown). TiTEL STELA analysis revealed that
DOX treatment did not induce any significant changes in tiTEL
length as compared to untreated controls, while tiTEL shortening
was readily detected in BIBR1532-treated cells as expected
(Figure 6A). In addition, concomitant treatments with DOX and
BIBR1532 shortened tiTELs to extents similar to the ones induced
by BIBR1532 only (Figure 6A). Similar results were obtained
when we analyzed the length of endogenous XpYp telomeres from
the same cells (Figure 6B). These results indicate that tiTERRA
transcription induction does not affect tiTEL length in a detectable
manner, even upon prolonged treatments.
We reasoned that our analysis of tiTEL length homeostasis in
cells treated with DOX could be biased by the fact that telomeres
were already at their homeostatic length when we first induced
tiTERRA transcription, while it is possible that TERRA-mediated
inhibition of telomerase could only be revealed when telomerase is
vigorously elongating telomeres. Therefore, we cultured cl12 and
cl17 cells in presence of BIBR1532 for about 60 PDs in order to
induce a substantial telomere shortening. At this point, no obvious
impairment of cell division rates was observed indicating that
telomeres were still long enough to sustain proper cell division
(data not shown). We then washed off the telomerase inhibitor and
cultured cells either in presence or absence of DOX over a time
course of 27 days. STELA analysis revealed that tiTELs were re-
Figure 5. Generation and characterization of transcriptionally inducible telomeres (tiTELs). (A) Scheme of the tiTEL seeding vector. iCMV:
inducible CMV promoter; SBF and SBR: oligonucleotides used in RT-PCR experiments; SBP: probe used in TRF, STELA and northern blot experiments.
(B) tiTEL TRF analysis of genomic DNA prepared from clone 12 (cl12), clone 17 (cl17) and parental (par) cells infected with hTERT-expressing
retroviruses or ev control retroviruses. DNA was hybridized using SBP probes. Marker molecular weights are on the left in kilobases. (C) Partial
metaphases from cl12 and cl17 hybridized in situ to detect tiTELs (arrowheads). (D) Northern blot analysis of total RNA from cl12 and cl17 treated for
24 h with combinations of doxycycline (DOX) and trichostatin A (TSA) or left untreated. SBP probes were used to detect tiTERRA. The same
membranes were stripped and re-probed to detect beta-actin transcripts (ACT) to control for loading. (E) qRT-PCR analysis of tiTERRA steady-levels in
the indicated cell lines treated with different combinations of DOX and TSA or left untreated. For each cell line, values are expressed as fold increase
over untreated samples. Bars and error bars are averages and standard deviations from 3 to 7 experiments. P values for relevant samples are indicated
by numbers or by the asterisks (*: P,0.01; **: P,0.001).
doi:10.1371/journal.pone.0035714.g005
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DOX-treated and untreated samples. TiTEL elongation rates
were: 67 and 71 bp/day for cl12 with and without DOX,
respectively, P.0.1 for treated vs untreated samples at each
analyzed time point; 58 and 61 bp/day for cl17 with and without
DOX, respectively, P.0.1 (Figure 7A and B). We therefore
conclude that tiTERRA transcription does not affect telomerase-
dependent tiTEL lengthening in our clones. As previously
explained for DKO cells, it remained possible that tiTERRA
levels could be down-regulated during S-phase, when telomerase
acts. Dot blot hybridization of RNA prepared from synchronized
cl12 and cl17 cells confirmed that tiTERRA was maintained at
higher levels in DOX-treated cells than in untreated controls
during S-phase, thus disproving the above mentioned hypothesis
(Figure S6). Our data clearly suggest that telomerase elongates
tiTELs through pathways that are not regulated by tiTERRA or
its transcription.
Conclusions
By using independent yet complementary cellular systems, we
have shown that telomerase-mediated telomere elongation is not
substantially affected by the transcriptional activity associated to
telomeres in human cancer cells. These observations argue against
Figure 6. TiTEL length homeostasis is maintained upon prolonged tiTEL transcription induction. Cl12 and cl17 cells were treated with
combinations of DOX and BIBR1532 (BIBR) for 60 population doublings. Genomic DNA was collected and STELA was performed for tiTELs (A) and
XpYp telomeres (B). Marker molecular weights are on the left in kilobases. The Whisker-boxplots on the left represent STELA quantifications. Average
(av) telomere lengths in kilobases and the number of total telomeres analyzed (n) are indicated for each sample.
doi:10.1371/journal.pone.0035714.g006
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general telomerase inhibitor, thereby contributing to maintain
telomere length homeostasis. It still remains possible that TERRA
could restrict telomerase activity in some particular contexts, for
example in a specific set of tissues or during development. Our
observations also indicate that the telomere shortening observed in
cells with augmented TERRA levels, such as yeast cells carrying
inducible telomeres, Rat1-deficient yeast cells, DKO cells and cells
from ICF patients [4,10,15], is unlikely to derive from telomerase
inhibition. One possible explanation is that the local increase of
TERRA molecules at hyper-transcribing telomeres could harm
their integrity for example by impairing replication. Supporting
this model, human cancer cells depleted for the RNA surveillance
factor UPF1 are characterized by aberrant accumulation of
TERRA molecules at telomeric heterochromatin and sudden loss
of telomeric sequences due to incomplete replication of the leading
strand telomere [3,29,30]. Our data also highlight that the in vitro
set up assembled using short TERRA-like oligonucleotides might
not recapitulate accurately the biological scenario where TERRA
is acting. Our tiTEL system could be used to carefully test to what
extent the results so far obtained in vitro underscore the in vivo
functions associated to TERRA and/or telomere transcription.
Materials and Methods
Cell culture procedures
HeLa, HEK293T, HLF, HCT116 par, HCT116 DKO and T-
Rex-HeLa (Invitrogen) cells were cultured in high-glucose D-
MEM (Gibco Life Technologies) supplemented with 10% of fetal
calf serum or tetracycline-free fetal calf serum for T-Rex-HeLa
cells, nonessential amino acids (Invitrogen), and penicillin/
streptomycin (Invitrogen). Where indicated, 1 mg/ml doxycycline
(Sigma-Aldrich), 200 ng/ml trichostatin A (Sigma-Aldrich), or
1 mM BIBR1532 (Tocris Bioscience) were added to the medium.
Plasmid transfections were performed using the Lipofectamine
2000 reagent (Invitrogen) according to the manufacturer’s
instructions. Retroviruses were produced in HEK 293T cells
according to standard procedures. Positively transfected or
infected cells were selected in medium containing 200 mg/mL
hygromycin (Fluka) or 1.5 mg/ml Puromycin (Sigma-Aldrich). For
cell synchronizations, cl12 and cl17 cells were blocked in G1/S
phase with 2 mg/ml aphidicolin (Sigma-Aldrich) for 20 h and
released into fresh medium after washing them twice in 16PBS.
HCT116 par and DKO cells were blocked in G2/M phase with
60 ng/ml nocodazole (Sigma-Aldrich) for 14–18 h. Mitotic cells
were collected by shake-off, washed three times in culture medium
Figure 7. Telomerase elongates tiTELs independently of their transcription induction. (A) Cl12 and cl17 cells were treated with BIBR1532
for 60 population doublings and released into normal medium in presence or absence of DOX. STELA analysis of tiTELs was performed 0, 3, 6, 9, 15,
20 and 27 days (d) after release. Marker molecular weights are on the left in kilobases. (B) Whisker-boxplots represent STELA quantifications for each
sample. Telomere elongation rates are expressed in base pairs per day (bp/d). All P-values between induced and uninduced samples were .0.1 and
therefore are not indicated. For each condition, 77 to 400 telomeres were analyzed.
doi:10.1371/journal.pone.0035714.g007
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different time points after release and cell cycle progression was
monitored by fluorescence-activated cell sorter (FACS) analysis of
propidium iodide-stained cells using a BD FACSCalibur flow
cytometer and the FlowJo software. To analyze cell viability, cells
were stained with 0.2% trypan blue (Sigma) and counted using the
Cellometer Auto T4 instrument (Nexcelom Bioscience). Apoptotic
cells were scored using the Annexin V-FITC Apoptosis Detection
Kit (eBioscience Diagnostics) according to manufacturers instruc-
tions.
Plasmids
TiTEL seeding plasmids were constructed by inserting a 1.6-kb-
long inverted luciferase cDNA downstream of the strong human
cytomegalovirus (CMV) immediate-early promoter followed by
two tetracycline operator sequences. A 1.2-kb-long (TTAGGG)n
stretch was excised from the plasmid pCMVTelo (kind gift from
Eric Gilson) and cloned immediately downstream of the Luciferase
sequence. Retroviral plasmids pBABE-puro-hTERT and pBABE-
puro-hTERT-HA were from Bob Weinberg’s laboratory and were
purchased from Addgene (plasmids 1771 and 1772). hTERT
expression was monitored by standard western blot analysis of
total protein extracts using rat monoclonal anti-hTERT antibodies
for total hTERT (kind gift from Elena Giulotto), rabbit polyclonal
anti-HA-tag antibodies for hTERT-HA (C29F4, Cell Signaling)
and mouse monoclonal anti-PCNA antibodies to control for
loading (sc-56, SantaCruz Biotechnology).
Telomere length analysis
Total genomic DNA was collected by standard phenol/
chloroform extraction or using the Wizard Genomic DNA
Purification Kit (Promega). For telomere restriction fragment
(TRF) analysis, 5 mg of genomic DNA were digested with RsaI
and/or HinfI. For tiTEL TRF analysis, 15 mg of genomic DNA
were digested with XhoI and SspI. For TERRA promoter
methylation analysis, 10 mg of DNA were digested either with
MspIo rHpaII. Restriction fragments were electrophoresed in
0.7% (for TRF analysis) or 1.2% agarose gels (for methylation
analysis) and transferred to nylon membranes (GE Osmonics).
Alternatively, gels were dried for in gel hybridization. Hybridiza-
tions were performed for 16 h at 50–64uC using radiolableled
DNA probes corresponding to a mixture of 1–5-kb-long telomeric
DNA fragments (teloA probe, to detect bulk telomeres), to
tiSUBTELs (SBP probe, to detect tiTELs), to 10q subtelomeric
sequences (10q probe, to detect 10q TRFs), or to 29–37 repeats
(29–37 probes, to detect TERRA promoter sequences). Post-
hybridization washes were done at 50–64uC in 0.2–0.56 SSC,
0.2% SDS. Radioactive signals were detected using a Typhoon
FLA 9000 phosphoimager (GE Healthcare). For STELA, 2 mgo f
DNA were digested with XhoIo rEcoRI and purified with the
GeneClean Turbo Kit (MP Biomedicals). 1 mlo f1 0mM telorette 3
or telorette 4 oligonucleotides was mixed with 20 ng of digested
DNA, incubated at 60uC for 10 min and cooled down to RT
before adding 0.1 ml of 100 mM ATP, 0.1 ml of 400 U/mlT 4
DNA ligase, 1 mlo f1 0 6 T4 DNA ligase buffer (New England
Biolabs) and water up to 20 ml. Reactions were incubated at 35uC
for 12 h and at 70uC for 15 min. 400 pg of ligated DNA were
PCR amplified in 15 ml reactions containing 0.5 mM TelTail
reverse primer, 0.5 mM forward primer (tiTEL-STELA, Xp/Yp-
STELA, or 15qF), 0.3 mM dNTPs, 5 mM Tris-HCl (pH 8.8),
200 mM (NH4)2SO4, 0.01% Tween-20, 0.5 mM MgCl2, 1.5 U of
Taq Thermoprime Polymerase (ABgene) and 0.15 U of Pwo
polymerase (Roche). PCR cycling was as follows: 15 sec at 94uC,
30 sec at 65uC, 10 min at 68uC for 25 cycles. Amplified fragments
were separated in 0.8% agarose gels and hybridized in gel using
radiolabeled TeloA probe, SBP probe or a probe corresponding to
15q subtelomeres (15q probe). Hybridizations and signal detection
were as for TRF analysis. For STELA analysis we used
QuantityOne and R software. For each gel lane the fragment
with the lowest intensity was considered as a single telomere and
the corresponding signal was used to normalize all other fragments
in the same lane. Molecular sizes were calculated using DNA
molecular weight markers run in the same gels. Calculated
telomere lengths were cumulated and used to compute average
telomere length. Data were represented in Box-Whisker-plots
showing the lowest value excluding outliers (data points that are
less than 1.5 times the lower quartile range), the lower quartile, the
median, the upper quartile and the highest value excluding outliers
(data points that are more than 1.5 times the upper quartile).
Outliers are represented by dots. For BAL31 experiments 20 mgo f
DNA were digested with 6 U of BAL31 (New England Biolabs)
and 2 mg aliquots were collected at the indicated time points, dot
blotted on nylon membranes and successively hybridized using
SBP, TeloA and Alu repeat probes.
RNA isolation and analysis
Total and nuclear RNA was prepared and digested with
rDNase using the NucleoSpin RNAII Kit (Macherey-Nagel). RNA
was additionally digested once for northern blot and dot blot
analysis or twice for qRT-PCR analysis using DNaseI (Qiagen).
For northern blotting, 10–15 mg of total or nuclear RNA were
separated in 1.2% agrose formaldehyde gels and transferred to
nylon membranes. For dot-blotting 1 mg of total RNA was spotted
to nylon membranes. Membranes were hybridized with SBP,
TeloA, 18S or b-actin radiolabeled probes as for genomic DNA
hybridizations. Radioactive signals were detected using the
Typhoon FLA 9000 phosphoimager and quantified using ImageJ
or Quantity One software (BioRad). For qRT-PCR analysis 2–
5 mg of total RNA were reverse-transcribed with Superscript II or
III reverse transcriptases (Invitrogen) using random hexamers
(New England Biolabs) or TeloC oligonucleotides and PCR
amplified using the LightCycler 480 SYBR Green I Master mix
(Roche) and the oligonucleotides listed in Table S1. PCR cycling
was 10 sec at 98uC and 30 sec at 60uC for 45 cycles using the
Rotor-Gene Q instrument (Qiagen). Averages, standard devia-
tions, and P-values (two-tailed Student’s t-test) were calculated
with Microsoft Excel software. For absolute quantifications we
generated standard curves using known amounts of plasmid DNA
containing tiTEL or 10q subtelomeric sequences.
Telomere repeat amplification protocol (TRAP) assays
For standard TRAP assays, 1610
6 cells were collected by
trypsinization and lysed for 20 minutes on ice in TRAP extraction
buffer (0.25 mM sodium deoxocholate, 1% Nonidet P-40,
150 mM NaCl, 10 mM Tris HCl pH 7.5, 1 mM MgCl2,1m M
EGTA, 10% glycerol, 1 mM DTT, 16 protease inhibitor
complex). Protein concentrations were determined using Bradford
assays and 0.1, 0.05 and 0.01 mg of total proteins were used for
TRAP reactions carried out as previously described [31].
Radioactive signals were detected and analyzed as above. qRT-
PCR-based TRAP assays were performed using the Quantitative
Telomerase Detection Kit (Allied Biotech Inc.) according to the
manufacturer’s instructions and the Rotor-Gene Q instrument
(Qiagen).
DNA and RNA fluorescence in situ hybridization (FISH)
DNA and RNA FISH experiments were carried out as
previously described with a few modifications [24,29,32]. For
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cl12 and cl17 cells and hybridized in situ using nick translation-
labeled biotinylated probes corresponding to the entire seeding
plasmid devoid of the telomeric tract. Before hybridization,
chromosomes were treated with 10 mg/ml RNaseA for 30 min
at 37uC and 0.005% pepsin in 0.01 N HCl for 20 minutes at
37uC. Chromosomes were then fixed in 4% paraformaldehyde
diluted in 16PBS. Each slide was hybridized with 300 ng of nick-
translated probe. Slides were than washed three times in 50%
formamide, 26SSC at 42uC and three times in 26SSC at 42uC.
For probe detection, slides were washed in 46 SSC, 0.05%
Tween-20, blocked in 5% milk in 46SSC, 0.05% Tween-20 for
30 minutes at RT and incubated with 5 mg/ml avidin-fluoresceine
(Vector Laboratories) in the same solution for 45 minutes at RT.
Slides were washed three times in 46SSC, 0.05% Tween-20 for
10 min at RT and then incubated with 5 mg/ml goat biotinylated
anti-avidin antibodies (Vector Laboratories) for 45 min at RT.
After three washes in 46SSC, 0.05% Tween-20, we performed a
second incubation with avidin-fluorescine for 45 minutes at RT
and washes. DNA was stained with 49,6-diamidino-2-phenylindole
(DAPI) and images were acquired using the Deltavision multi-
plexed system (Applied Precision). For RNA FISH cells plated on
coverslips were first incubated with mouse monoclonal anti-
human TRF2 primary antibodies (4A794, Millipore) and succes-
sively with donkey anti-mouse secondary antibody conjugated with
Alexa 488 (Invitrogen). Cells were fixed in 4% paraformaldehyde
and subjected to RNA FISH using TeloA probes labeled with
Cy3-dCTP (Perkin Elmer). Images were taken as 0.2 mm Z-stacks
using the Deltavision Multiplexed system (Applied Precision).
TRF2 and TERRA foci were analyzed using the spot detection
and co-localization applications of the Imaris software (Bitplane).
Foci were estimated to have an average diameter of 0.7 mm and
they were considered to be co-localizing when found to be 0.6 mm
or less apart from each other.
Supporting Information
Figure S1 Shows that TERRA steady-state levels are not
affected by telomere elongation in human primary
fibroblasts. (A) TRF analysis of human lung primary fibroblasts
(HLF) infected with empty vector (ev), hTERT or hTERT-HA
retroviruses. DNA was digested with RsaI and HinfI restriction
enzymes and hybridized with telomeric probes. (B) The same
DNA as in A was digested with HpaII (methylation sensitive) or
MspI (methylation insensitive) restriction nucleases and hybridized
with a probe detecting the 29–37 bp repeats of TERRA
promoters. (C) Total RNA was hybridized using telomeric probes
to detect total TERRA and successively with beta-actin (ACT)
probes to control for loading. Numbers at the bottom are the ratios
between TERRA and actin signals expressed as fold increase over
ev-infected samples. Molecular weights are on the left in kilobases.
(D) qRT-PCR analysis of the steady-state levels of TERRA
transcripts originating from 10q, 15q and Xp/Yp chromosome
ends. Bars are averages from three independent experiments
expressed as fold increase over ev-infected samples. Error bars and
numbers are standard deviations and P-values, respectively.
*: P,0.01. (E) Western blot analysis of infected cells using anti-
hTERT (to detect all hTERT molecules), anti-HA (to detect
hTERT-HA) and anti-PCNA (loading control) antibodies.
(TIF)
Figure S2 Shows 10q TERRA steady-state levels, cellu-
lar state and TERRA localization in par and DKO cells
upon telomere elongation. (A) Total RNA was hybridized
using probes to detect TERRA molecules transcribed from 10q
subtelomeres in the indicated cell lines. The same membrane was
stripped and hybridized with 18S rRNA probes to control for
loading. Molecular weights are on the left in kilobases. (B) Top:
examples of FACS analysis of Annexin V and propidium iodide
stained cells. Bottom: quantifications of alive cells (trypan blue
negative cells), apoptotic cells (Annexin V – AV – positive cells)
and cells in the different phases of the cell cycle as judged by
propidium iodide (PI) staining. Values are averages and standard
deviations form three independent experiments. (C) Examples of
anti-TRF2 indirect immunofluorescence combined with TERRA
RNA FISH in the par and DKO cells infected with hTERT or
empty vector (ev) retroviruses. In the merge panels TRF2 is in
green, TERRA in red and DAPI-stained DNA in blue. (D)
Quantification of co-localization of TRF2 and TERRA foci. Bars
and error bars are averages and standard deviations of co-
localization events per nucleus. For each condition 50 nuclei were
analyzed.
(TIF)
Figure S3 Shows TERRA steady-state levels in synchro-
nized par and DKO cells. (A) FACS profiles of propidium
iodine-stained cells blocked in G2/M using nocodazole and
released into the cell cycle for the indicated hours. (B) Dot-blot
analysis of total RNA isolated at indicated hours after release. The
same membranes were first hybridized with telomeric probes (to
detect TERRA), stripped and re-hybridized with beta-actin probes
to control for loading. (C) Quantification of dot blots as in B.
TERRA values were normalized through the corresponding actin
values and expressed as fold increase over par cells at time 0. Bars
and error bars represent averages and standard deviations from
two independent experiments.
(TIF)
Figure S4 Shows the characterization of tiTELs in cl12
and cl17 cells. (A) TRF analysis of bulk telomeres using HinfI
and RsaI-digested DNA hybridized to telomeric probes. (B)
Control experiments demonstrating specificity of tiTEL STELAs.
Nt: no template control. The same membrane was first hybridized
using SBP probes, stripped and re-hybridized using telomeric
probes. (C) Dot blot hybridization of BAL31-digested genomic
DNA from parental (par), cl12 and cl17 cells. The same
membrane was hybridized successively to detect tiTEL, telomeric
repeat and alu repeat DNA. Radioactive signals associated to the
three hybridizations are quantified below. Note that alu signals
remain constant throughout the time course, while telomeric and
tiTEL signals gradually diminish in both clonal cell lines.
(TIF)
Figure S5 Shows the characterization of tiTEL tran-
scription induction in cl12 and cl17 cells. (A) Sketch of
oligonucleotides used in RT-PCR experiments. TelC oligonucle-
otides were used for RT, SBF and SBR oligonucleotides were used
for PCR. (B) Absolute quantification of tiTERRA (ti) and natural
TERRA transcribed from 10q chromosome ends in cl12 and cl17
cells treated or not with DOX. (C) Agarose gel analysis of
tiTERRA RT-PCR products from cl12 and cl17 cells treated or
not with DOX.
(TIF)
Figure S6 Shows tiTERRA and total TERRA steady-state
levels in synchronized cl12 and cl17 cells. (A) FACS profiles
of propidium iodine-stained cells blocked in G1/S using
aphidicolin and released into the cell cycle for the indicated hours
in presence or absence of DOX. (B) Dot blot analysis of total RNA
isolated at indicated hours after release. The same membranes
were hybridized successively with SBP (to detect tiTERRA),
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probes. (C) Quantification of dot-blots as in B. TERRA values
were normalized through the corresponding actin values and
expressed as fold increase over unsynchronized, untreated cells.
Points and error bars represent averages and standard deviations
from two independent experiments.
(TIF)
Table S1 Shows the oligonucleotides used in this study.
(DOCX)
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